Jenrin Discovery Announces Recent Advances in Understanding of the Endocannabinoid System Using JD-5037
September 11, 2013 15:59 ET | Jenrin Discovery, LLC
Mechanism of Action of Peripheral CB1 Inverse Agonists Suggests Potential Clinical Utility in Metabolic Disorders PHILADELPHIA, Sept. 11, 2013 (GLOBE NEWSWIRE) -- Research published in Nature...